14 SI Trademark

Trademark Overview


On Friday, June 5, 2020, a trademark application was filed for 14 SI with the United States Patent and Trademark Office. The USPTO has given the 14 SI trademark a serial number of 79295832. The federal status of this trademark filing is REGISTERED as of Tuesday, April 26, 2022. This trademark is owned by Veritas In Silico Inc.. The 14 SI trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Educational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, phar...

Designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; pharmaceutical, medicine and chemical industrial design services for use in medicines and engineering design services, not for advertising; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer...
14 si

General Information


Serial Number79295832
Word Mark14 SI
Filing DateFriday, June 5, 2020
Status700 - REGISTERED
Status DateTuesday, April 26, 2022
Registration Number6708925
Registration DateTuesday, April 26, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements


Goods and ServicesEducational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering, images and character text information, non-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; art exhibitions; publication of books; movie theatre presentations, namely, movie showing and movie film production and distribution; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity
Description of MarkThe mark consists of the numerals "14" and the letters "SI" in black within a red square.
Pseudo MarkONE FOUR SI; FOURTEEN SI
Indication of Colors claimedThe color(s) black and red is/are claimed as a feature of the mark.
Goods and ServicesDesigning of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; pharmaceutical, medicine and chemical industrial design services for use in medicines and engineering design services, not for advertising; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; data conversion of electronic information using computers technological advice relating to computers, automobiles and other industrial machines requiring highly specialized knowledge, skills and experiences for proper operation, namely, computer technology consultancy, automobile transmission diagnostic consulting and industrial machine part design consulting; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; quality control assessment services for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of chemicals or reagents; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific research consultancy, advice and providing information in the field of genomic experiments, analyses, research, assays, tests, inspection, detection or verification; scientific and technological services, namely, testing, analysis surveying, research or data analysis in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials and bioengineering; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for others; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on machines, apparatus and instruments, namely, testing the functionality of machines, research on machines and technology research in the field of medical instruments and drug manufacturing machines; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; cloud server storage services on the internet for electronic files; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing online non-downloadable computer software for analyzing, testing, screening, designing, development and research of nucleic acids, pharmaceuticals and chemicals; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for genome research and development research of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments and foodstuffs; rental of laboratory apparatus and instruments

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeritas In Silico Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2020ASSIGNED TO EXAMINER
Friday, October 23, 2020APPLICATION FILING RECEIPT MAILED
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 26, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 17, 2020REFUSAL PROCESSED BY MPU
Tuesday, November 17, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 7, 2020REFUSAL PROCESSED BY IB
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 11, 2021FINAL REFUSAL WRITTEN
Friday, June 11, 2021FINAL REFUSAL E-MAILED
Friday, June 11, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, November 30, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, November 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 4, 2022ASSIGNED TO LIE
Wednesday, January 5, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 19, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 19, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Monday, March 7, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, March 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 31, 2022FINAL DISPOSITION PROCESSED
Monday, April 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, April 26, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 11, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 20, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 31, 2022FINAL DISPOSITION NOTICE SENT TO IB